<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01268696</url>
  </required_header>
  <id_info>
    <org_study_id>RNN/202/10/KE</org_study_id>
    <nct_id>NCT01268696</nct_id>
  </id_info>
  <brief_title>Genetic Assessment of the Patients With Metabolic Syndrome</brief_title>
  <acronym>GENMetS</acronym>
  <official_title>Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lodz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lodz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metabolic syndrome is a combination of medical disorders that increase the risk of developing&#xD;
      cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of&#xD;
      metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and&#xD;
      has been only partially elucidated. Most patients are older, obese, sedentary, and have a&#xD;
      degree of insulin resistance. Stress can also be a contributing factor. The most important&#xD;
      factors are:&#xD;
&#xD;
      weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will&#xD;
      assess the role of some polymorphisms in the pathology of metabolic syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligibility criteria to the study:&#xD;
&#xD;
        -  patients with metabolic syndrome&#xD;
&#xD;
        -  with written consent&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>healthy volunteers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metabolic group</arm_group_label>
    <description>Patients with metabolic syndrome</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      the blood samples taken into EDTA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with metabolic syndrome&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with metabolic syndrome according to IDF,AHA and NHLBI 2009&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diabetes type 1&#xD;
&#xD;
          -  cancer&#xD;
&#xD;
          -  not consent&#xD;
&#xD;
          -  steroid therapy&#xD;
&#xD;
          -  alcohol or drug abuse&#xD;
&#xD;
          -  chronic inflammatory disease&#xD;
&#xD;
          -  pregnancy or lactation&#xD;
&#xD;
          -  severe hypothyroidism&#xD;
&#xD;
          -  immunosuppressive treatment&#xD;
&#xD;
          -  operation or severe injury during the last month&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tadeusz Pietrucha, prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of medical biotechnology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of medical biotechnology Medical University of Lodz</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <study_first_submitted>December 28, 2010</study_first_submitted>
  <study_first_submitted_qc>December 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2010</study_first_posted>
  <last_update_submitted>July 20, 2011</last_update_submitted>
  <last_update_submitted_qc>July 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Department of Medical Biotechnology</name_title>
    <organization>Medical University of Lodz</organization>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>obesity</keyword>
  <keyword>hypertension</keyword>
  <keyword>dyslipidemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

